Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technology

Descrizione del progetto

Tecnologia avanzata di bioimmagine

Esiste un bisogno insoddisfatto a livello mondiale di diagnosi accurate e di analisi microscopiche decentrate e in contesti a basse risorse, poiché le infrastrutture esistenti sono ingombranti e costose. Finanziato dal Consiglio europeo per l’innovazione, il progetto DISRUPT sta sviluppando una nuova tecnologia lab-on-chip chiamata «microscopia tomografica integrata», che rivoluzionerà il campo dell’imaging biomedico. Combinando tecnologie all’avanguardia e intelligenza artificiale, il consorzio svilupperà microscopi tomografici molto più economici, leggeri e piccoli. Si prevede che questi microscopi migliorati troveranno applicazione nella diagnosi e nella ricerca sul cancro, nonché nella telemedicina, offrendo una migliore risoluzione, sensibilità ed efficienza energetica.

Obiettivo

DISRUPT aims at revolutionising the field of biomedical imaging by developing a radically new lab-a-on-chip technology: integrated tomographic microscopy. This unprecedented technique will be enabled by pushing forward the science of on-chip wireless photonics and tomography, in combination with microfluidics and artificial intelligence (AI). The CMOS compatibility of this technology represents a paradigm shift as it assures the realization of tomographic microscopes that are dramatically cheaper, lighter, and smaller than current approaches. Moreover, the singular features of the proposed solution introduce key advantages in terms of resolution, sensitivity, throughput, parallelisation, and energy efficiency. To illustrate its potential, we will show that on-chip TPM can be used for cancer detection and the identification of infected cells. Developments related to fundamental nanoantenna and diffraction tomography science, nanophotonics, nanofabrication, microfluidics, AI and clinical validation will be undertaken by a consortium comprised by 2 SME, 1 HE, 1 Non-profit RO and 2 Cancer R&D Medical institutions, with complementary expertise, leaders in their respective markets and R&D fields. This novel device is suited for many applications, such as early cancer diagnosis, cell characterisation, research on cancer and infectious diseases, immunocyte phenotyping, stem cell multipotency identification, tissue pathology, haematopathology, and analysis of infected cells. Its intrinsic mass-producible, compact, low-cost, mechanically robust, and energy-efficient feature makes this technology a future innovation driver for new developments in many biomedical application fields, and offers an alternative toolset addressing some of the emerging needs of microscopic analysis and diagnostics in low-resource settings, telemedicine applications and point-of-care, having a potentially huge societal impact fostering early diagnosis of cancer and other diseases and infections.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-EIC - HORIZON EIC Grants

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) HORIZON-EIC-2022-PATHFINDEROPEN-01

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

UNIVERSITAT POLITECNICA DE VALENCIA
Contributo netto dell'UE
€ 785 750,00
Indirizzo
CAMINO DE VERA SN EDIFICIO 3A
46022 Valencia
Spagna
Regione
Este Comunitat Valenciana Valencia/València
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 785 750,00

Partecipanti (5)